Legislative Activity

The Jewish American Security Act addresses the rising threat of antisemitism across the nation. This bill mandates new protections for Jewish students in educational settings and significantly increases funding and administrative support for securing Jewish community institutions. Furthermore, it requires increased transparency from large online platforms regarding their moderation of antisemitic content and mandates federal assessments of domestic and transnational antisemitic threats.

The American High-Speed Rail Act significantly expands federal support for high-speed and higher-speed rail development by increasing funding limits, broadening eligibility for public-private partnerships, and establishing new planning and safety requirements. The bill authorizes substantial funding through 2031 for corridor development and planning, while also creating pathways for acquiring necessary right-of-way property and ensuring labor protections on federally-funded infrastructure. It also refines definitions, setting the threshold for true "high-speed rail" at 186 mph or more, and introduces a new category for "higher-speed rail."

The Ensuring Community Access to Pharmacist Services Act expands Medicare Part B coverage to include services provided by pharmacists starting January 1, 2026. This coverage is specifically for testing or treatment related to COVID-19, the flu, RSV, strep throat, or during a declared public health emergency. The bill outlines payment structures, generally covering 80% of the cost, and prohibits pharmacists from balance billing Medicare patients for these covered services.

The Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 extends vital funding and research support for ALS therapies through 2031. This legislation enhances grant oversight, clarifies clinical trial definitions, and mandates updated FDA action plans to improve the development of treatments for ALS and other rare neurodegenerative diseases.

This bill authorizes the Secretary of the Treasury to mint and issue commemorative gold and silver coins marking the 25th anniversary of the September 11, 2001, terrorist attacks. The coins will honor the victims, first responders, and survivors, with designs selected in consultation with the National September 11 Memorial and Museum. All surcharges from the sale of these coins will be paid directly to the Memorial and Museum to support its operations and maintenance.

The Build Nuclear with Local Materials Act of 2026 directs the Nuclear Regulatory Commission to authorize the use of standard commercial-grade steel and concrete in non-safety-related structures at nuclear power plants. This aims to streamline construction by reducing regulatory hurdles for commonly used materials. The NRC can only impose stricter standards if commercial materials pose a specific safety risk.

The Universal School Meals Program Act of 2026 establishes permanent, universal free breakfast and lunch programs for all enrolled students at participating schools, eliminating income tests and meal debt collection. The bill significantly updates federal funding mechanisms by replacing reliance on free and reduced-price lunch data with new measures for identifying economically disadvantaged students across various education and social programs. Furthermore, it expands access to summer and afterschool meals while making technical amendments across several federal education and nutrition laws.

The Patients Before Monopolies Act aims to break up conflicts of interest within the healthcare industry by prohibiting entities from simultaneously owning a Pharmacy Benefit Manager (PBM) or insurer alongside a pharmacy. This legislation mandates the divestiture of such integrated businesses to foster competition and reduce prescription drug costs. It grants the FTC and DOJ significant authority to enforce this structural separation and allows civil actions, including by private citizens, to ensure compliance.

The Screen-time Management And Recommendations for Teens and Kids Act (SMART Kids Act) directs the Surgeon General to develop evidence-informed, age-specific recommendations for daily screen time limits for children and teens. These guidelines must be created in collaboration with an independent, unbiased expert entity. The final recommendations must be published within one year of the bill's enactment.

This resolution expresses support for designating July 15, 2026, as Glioblastoma Awareness Day. It aims to raise public awareness about glioblastoma, the most aggressive malignant brain tumor, and honor those affected by the disease. The bill encourages greater investment in research and collaboration to develop improved treatments and outcomes for patients.

This bill amends the House of Representatives' rules to prohibit Members, officers, and employees from participating in certain prediction markets involving excluded commodities. The legislation aims to prevent conflicts of interest by banning trades tied to the outcome of specific events. It also expresses the sense of the House that the executive and judicial branches should adopt similar restrictions.

This bill directs the President to withdraw U.S. Armed Forces from hostilities involving Iran, unless those forces are necessary for imminent self-defense or the defense of an ally. The removal must comply with the War Powers Resolution reporting requirements. This directive ceases if Congress issues a formal declaration of war or specific authorization for military force against Iran.

The Baltic Security Assessment Act of 2025 affirms the critical importance of Estonia, Latvia, and Lithuania to U.S. national security amidst Russian aggression. This bill mandates that the Secretary of State and Secretary of Defense deliver a comprehensive report to Congress detailing emerging military, cyber, and political threats to the Baltic states. The report must also recommend specific actions to enhance U.S. and NATO defense cooperation and bolster Baltic resilience.

The Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 mandates that Medicare Part D plans prioritize lower-cost generic and biosimilar drugs on their formularies starting in 2027. By requiring these medications to be placed in preferred tiers and prohibiting restrictive access barriers, the bill aims to reduce out-of-pocket costs for seniors.

The GUARDRAILS Act repeals the December 11, 2025, Executive Order regarding national AI policy. This legislation prohibits the use of federal funds to implement or enforce the mandates set forth in that order.

The Momnibus Act is a comprehensive legislative package designed to end preventable maternal mortality and close racial and ethnic disparities in maternal health outcomes. By addressing social determinants of health, expanding nutritional and mental health support, and investing in a diverse, culturally competent workforce, the bill provides a holistic framework for improving care. Through targeted federal grants, enhanced data collection, and innovative technology, the Act aims to ensure that all pregnant and postpartum individuals receive the equitable, high-quality care they deserve.

The Enhanced Iran Sanctions Act of 2025 strengthens U.S. policy by imposing mandatory sanctions on foreign persons and financial institutions that support Iran’s nuclear, ballistic missile, drone, and terrorist activities. The bill specifically targets Iran’s petroleum and petrochemical sectors to cut off funding for these malign programs. Additionally, it expands the State Department’s "Rewards for Justice" program to incentivize the reporting of individuals who evade these sanctions.

The Medicaid VBPs for Patients (MVP) Act updates federal drug pricing regulations to formally support value-based purchasing arrangements in Medicaid and Medicare. By refining how drug prices are calculated and providing guidance for state-level implementation, the bill aims to improve patient access to innovative therapies while ensuring better health outcomes. Additionally, it creates necessary legal exceptions for these arrangements and mandates a GAO study to evaluate their long-term impact on costs and patient care.

The America’s Living Library Act establishes a pilot program within the Department of the Interior to collect, sequence, and create a public database of genomic data from plants, animals, fungi, and microbes in national parks. This initiative mandates coordination across federal agencies for sample collection, long-term physical storage, and data integration with existing scientific systems. The bill authorizes specific funding for the project and supporting agencies through fiscal year 2031, with the program terminating ten years after enactment.

The Cloud LAB Act of 2026 establishes a national pilot program to create a network of automated, remotely operated biotechnology laboratories. By funding these "cloud laboratories," the initiative aims to accelerate research, generate high-quality biological data for artificial intelligence training, and provide scientists with secure, centralized access to advanced experimental tools.